These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9547588)

  • 21. Characterization of ciprofibrate and clofibric acid as peroxisomal proliferators in primary cultures of rat hepatocytes.
    Feller DR; Singh Y; Shirhatti VR; Kocarek TA; Liu CT; Krishna G
    Hepatology; 1987; 7(3):508-16. PubMed ID: 3570161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids.
    Intrasuksri U; Rangwala SM; O'Brien M; Noonan DJ; Feller DR
    Gen Pharmacol; 1998 Aug; 31(2):187-97. PubMed ID: 9688458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Irreversible inhibition of hepatic glutathione S-transferase by ciprofibrate, a peroxisome proliferator.
    Awasthi YC; Singh SV; Goel SK; Reddy JK
    Biochem Biophys Res Commun; 1984 Sep; 123(3):1012-8. PubMed ID: 6487318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of the DNA binding activity of AP-1 by the peroxisome proliferator ciprofibrate and eicosanoids in cultured rat hepatocytes.
    Hong JT; Glauert HP
    Toxicology; 1998 Nov; 131(2-3):99-107. PubMed ID: 9928625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perfluorodecanoic acid as a useful pharmacologic tool for the study of peroxisome proliferation.
    Vanden Heuvel JP
    Gen Pharmacol; 1996 Oct; 27(7):1123-9. PubMed ID: 8981056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicological evaluation of peroxisome proliferators. Further cellular and molecular aspects.
    Passilly P; Pacot C; Jannin B; Cherkaoui Malki M; Bardot O; Caira F; Clemencet MC; Latruffe N
    Ann N Y Acad Sci; 1996 Dec; 804():716-8. PubMed ID: 8993603
    [No Abstract]   [Full Text] [Related]  

  • 27. Induction of peroxisomal enzymes in cultured porcine endothelial cells by the hypolipidemic drug ciprofibrate.
    Glauert HP; Hennig B; Chow HS
    J Biochem Toxicol; 1990; 5(2):115-8. PubMed ID: 2283660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rodent hepatocarcinogenic peroxisome proliferators induce proliferation of rat hepatocytes in primary mixed cultures with rat liver epithelial cells.
    Perrone CE; Williams GM
    Cancer Lett; 1998 Jan; 123(1):27-33. PubMed ID: 9461014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of the peroxisome proliferator ciprofibrate on the gastric mucosa and particularly the gastrin cell.
    Waldum HL; Kvetnoi IM; Sylte R; Schulze B; Martinsen TC; Sandvik AK
    J Mol Endocrinol; 1998 Feb; 20(1):111-7. PubMed ID: 9513087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 32P-postlabeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro.
    Gupta RC; Goel SK; Earley K; Singh B; Reddy JK
    Carcinogenesis; 1985 Jun; 6(6):933-6. PubMed ID: 4006083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciprofibrate represses alpha 2u-globulin expression in liver and inhibits d-limonene nephrotoxicity.
    Alvares K; Subbarao V; Rao MS; Reddy JK
    Carcinogenesis; 1996 Feb; 17(2):311-6. PubMed ID: 8625456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed effects of ciprofibrate on rat liver peroxisomal properties and proto-oncogene expression.
    Bardot O; Clemencet MC; Cherkaoui Malki M; Latruffe N
    Biochem Pharmacol; 1995 Sep; 50(7):1001-6. PubMed ID: 7575654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of ciprofibrate and 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme activities in rats. Relation between hepatic carnitine concentration and carnitine acetyltransferase activity.
    Bhuiyan AK; Bartlett K; Sherratt HS; Agius L
    Biochem J; 1988 Jul; 253(2):337-43. PubMed ID: 3178716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of joint exposures to selected peroxisome proliferators on hepatic acyl-CoA oxidase activity in male B6C3F1 mice.
    Ochs JB; Baldwin LA; Leonard DA; Calabrese EJ
    Hum Exp Toxicol; 1992 Mar; 11(2):83-8. PubMed ID: 1349224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiating hypergastrinemic effect by the peroxisome proliferator ciprofibrate and omeprazole in the rat.
    Hammer TA; Sandvik AK; Waldum HL
    Scand J Gastroenterol; 1998 Jun; 33(6):595-9. PubMed ID: 9669630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An in vitro demonstration of peroxisome proliferation and increase in peroxisomal beta-oxidation system mRNAs in cultured rat hepatocytes treated with ciprofibrate.
    Thangada S; Alvares K; Mangino M; Usman MI; Rao MS; Reddy JK
    FEBS Lett; 1989 Jul; 250(2):205-10. PubMed ID: 2753129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotoxic effects of selected peroxisome proliferators.
    Reisenbichler H; Eckl PM
    Mutat Res; 1993 Apr; 286(2):135-44. PubMed ID: 7681524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential regulation by a peroxisome proliferator of the different multifunctional proteins in guinea pig: cDNA cloning of the guinea pig D-specific multifunctional protein 2.
    Caira F; Clémencet MC; Cherkaoui-Malki M; Dieuaide-Noubhani M; Pacot C; Van Veldhoven PP; Latruffe N
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1361-8. PubMed ID: 9494107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response of genetically obese Zucker rats to ciprofibrate, a hypolipidemic agent, with peroxisome proliferation activity as compared to Zucker lean and Sprague-Dawley rats.
    Pacot C; Petit M; Caira F; Rollin M; Behechti N; Grégoire S; Cherkaoui Malki M; Cavatz C; Moisant M; Moreau C
    Biol Cell; 1993; 77(1):27-35. PubMed ID: 8518742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of mitochondrial respiration and oxygen-dependent hepatotoxicity by six structurally dissimilar peroxisomal proliferating agents.
    Keller BJ; Yamanaka H; Thurman RG
    Toxicology; 1992; 71(1-2):49-61. PubMed ID: 1729767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.